Ischaemic preconditioning for liver transplantation

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2008, Pages

  Gurusamy, Kurinchi S ^a   Kumar, Y ^b   Sharma, D ^b   Davidson, B R ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; AMINOTRANSFERASE; BILIRUBIN; CD8 ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; MYELOPEROXIDASE; PROTHROMBIN;

APOPTOSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ENZYME ACTIVITY; GRAFT RECIPIENT; HOSPITALIZATION; HUMAN; INTENSIVE CARE; ISCHEMIA; ISCHEMIC PRECONDITIONING; LEUKOCYTE ACTIVATION; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER INJURY; LIVER TRANSPLANTATION; LIVING DONOR; MORTALITY; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; RETRANSPLANTATION; REVIEW; RISK FACTOR;

EID: 44949189559     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006315.pub2     Document Type: Review

References (37)

1. Amador 2004 {published data only} *Amador A, Marti J, Rodriguez-Laiz G, Bombuy E, Alvarez G, Ferrer J, et al.Ischemic preconditioning during donor procurement in orthotopic liver transplantation. Preliminary results of a prospective and randomized trial. Journal of Hepatology 2004;40(Suppl 1):37.
2. Amador MA, Marti J, Alvarez G, Rodriguez GP, Bombuy E, Ferrer J, et al.Ischemic preconditioning during donor procurement in orthotopic liver transplantation. Preliminary results of a prospective and randomized trial. Liver Transplantation 2004;10(6):C35.
3. Bombuy 2004 {published data only} Bombuy E, Fondevila C, Rodriguez-Laiz G, Ferrer J, Amador A, Valentini M, et al.Ischemic preconditioning in adult living donor liver transplantation, a pilot study [EASL abstract]. Journal of Hepatology 2004;40(Suppl 1):39.
4. Cescon 2006 {published data only} Cescon M, Grazi GL, Grassi A, Ravaioli M, Vetrone G, Ercolani G, et al.Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study. Liver Transplantation 2006;12(4):628-35.
5. Koneru 2005 {published data only} *Koneru B, Fisher A, He Y, Klein KM, Skurnick J, Wilson DJ, et al.Ischemic preconditioning in deceased donor liver transplantation: a prospective randomized clinical trial of safety and efficacy. Liver Transplantation 2005;11(2):196-202.
6. Koneru B, Fisher A, Skurnick J, Klein K, He Y, Wilson D, et al.Ischemic preconditioning in cadaver donor liver transplantation: a prospective randomized clinical trial of safety and efficacy. American Journal of Transplantation 2004;4(s8):507.
7. Banga 2005 Banga NR, Homer-Vanniasinkam S, Graham A, Al-Mukhtar A, White SA, Prasad KR. Ischaemic preconditioning in transplantation and major resection of the liver. The British Journal of Surgery 2005;92(5):528-38.
8. Clavien 2003 Clavien PA, Selzner M, Rudiger HA, Graf R, Kadry Z, Rousson V, et al.A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Annals of Surgery 2003;238(6):843-50; discussion 851-2.
9. Corno 2006 Corno V, Colledan M, Dezza MC, Guizzetti M, Lucianetti A, Maldini G, et al.Extended right split liver graft for primary transplantation in children and adults. Transplantation International 2006;19(6):492-9.
10. DeMets 1987 DeMets DL. Methods for combining randomized clinical trials: strengths and limitations. Statistics in Medicine 1987;6(3):341-50.
11. DerSimonian 1986 DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88.
12. Egger 1997 Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Research Ed.) 1997;315(7109):629-34.
13. Gluud 2007 Gluud C, Nikolova D, Klingenberg SL, Als-Nielsen B, D'Amico G, Davidson B, et al.Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2007, Issue 2. Art. No.: LIVER.
14. Higgins 2002 Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21(11):1539-58.
15. Higgins 2006 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley & sons, Ltd.
16. Kamath 2001 Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al.A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33(2):464-70.
17. Kjaergard 2001 Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001;135(11):982-9.
18. Kohler 2002 Kohler C, Orrenius S, Zhivotovsky B. Evaluation of caspase activity in apoptotic cells. Journal of Immunological Methods 2002;265(1-2):97-110.
19. Koti 2003 Koti RS, Seifalian AM, Davidson BR. Protection of the liver by ischemic preconditioning: a review of mechanisms and clinical applications. Digestive Surgery 2003;20(5):383-96.
20. Lim 2006 Lim SG, Wai CT, Da Costa M, Sutedja DS, Lee YM, Lee KH, et al.Referral patterns and waiting times for liver transplantation in Singapore. Singapore Medical Journal 2006;47(7):599-603.
21. Macaskill 2001 Macaskill P, Walter SD, Irwig L. A comparison of methods to detect publication bias in meta-analysis. Statistics in Medicine 2001;20(4):641-54.
22. Maruyama 2004 Maruyama Y, Lindholm B, Stenvinkel P. Inflammation and oxidative stress in ESRD - the role of myeloperoxidase. Journal of Nephrology 2004;17(Suppl 8):S72-S76.
23. Moher 1998 Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al.Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352(9128):609-13.
24. Moher 2001 Moher D, Schulz KF, Altman DG (for the CONSORT Group). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357(9263) :1191-4.
25. NCBI 2006a NCBI. MeSH. Ischemic preconditioning. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= mesh&list_uids=68019194&dopt=Full (accessed 19 April 2007).
26. NCBI 2006b NCBI. MeSH. Apoptosis. http://www.ncbi.nlm.nih.gov/ entrez/query.fcgi?cmd=Retrieve&db=mesh&list_uids=68017209&dopt=Full (accessed 19 April 2007).
27. NCBI 2006c NCBI. Entrez Protein. NP 004337. caspase 3 preproprotein [Homo sapiens]. Comment. http://www.ncbi.nlm.nih.gov/entrez/ viewer.fcgi?db=protein&val=14790119 (accessed 19 April 2007).
28. NCBI 2006d NCBI. MeSH. Antigens, CD8. http://www.ncbi.nlm.nih.gov/ entrez/query.fcgi?cmd=Retrieve&db=mesh&list_uids=68016827&dopt=Full (accessed 19 April 2007).
29. Newell 1992 Newell DJ. Intention-to-treat analysis: implications for quantitative and qualitative research. International Journal of Epidemiology 1992;21(5):837-41.
30. NHS UK Transplant NHS UK Transplant - Annual Report 2003-2004. http://www.uktransplant.org.uk/ukt/about_us/annual_report/ archive_annual_reports/ann_report_2003_2004.pdf (accessed 19 April 2007).
31. OPTN 2007 The organ procurement and transplantation network. Donors recovered in the US by donor type. http://www.optn.org/latestData/ rptData.asp 2007 (last accessed on 09/09/07).
32. OPTN/SRTR 2005 The Organ Procurement and Transplant Network/ Scientific Registry of Transplant Recipients 2005 Annual Report. http://www.ustransplant.org/annual_reports/current/905_li.pdf (accessed 19 April 2007).
33. RevMan 2003 Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2003.
34. Royle 2003 Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003;19(4):591-603.
35. Schulz 1995 Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408- 12.
36. Shiffman 2006 Shiffman ML, Saab S, Feng S, Abecassis MI, Tzakis AG, Goodrich NP, et al.Liver and intestine transplantation in the United States, 1995-2004. American Journal of Transplantation 2006;6(5 Pt 2):1170-87.
37. Sweeting 2004 Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Statistics in Medicine 2004;23(9):1351-75.